RxDoctor Payments Data

Catherine Gordon, NP

Family · Flat Rock, NCNPI 1811208648

Payments from drug & device makers

$316in general payments, 2019–2025

Across 18 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$94
  • Pfizer$46
  • AstraZeneca$37
  • Novo Nordisk$37
  • Amgen$34
  • Daiichi Sankyo Inc.$24
  • plus $44 from 2 others

What the payments were for

  • Food & beverage$316100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$316 in reported general payments places this provider in the 45th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$59,417
Medicare patients
137
Services billed
722

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban71$75,762
JardianceEmpagliflozin55$64,137
OzempicSemaglutide34$36,588
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$34,869
Tresiba Flextouch U-100Insulin Degludec17$18,408
SynthroidLevothyroxine Sodium47$3,975
Fentanyl12$2,768
Levothyroxine Sodium252$2,637
Atorvastatin Calcium315$2,418
Rosuvastatin Calcium262$2,203
Potassium Chloride83$2,179
Gabapentin128$1,968
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,492
Ezetimibe54$1,416
Omeprazole149$1,412

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$46$75,76271 claims
Novo NordiskOzempic$37$36,58834 claims
GSKTrelegy Ellipta$20$34,86926 claims
AbbVieSynthroid$94$3,97547 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 4,522 family providers in North Carolina.

Other family in Flat Rock

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →